Marlow Hernandez - 31 Aug 2021 Form 4 Insider Report for Cano Health, Inc. (CANO)

Role
CEO and President, Director
Signature
/s/ David Armstrong, Attorney-in-Fact
Issuer symbol
CANO
Transactions as of
31 Aug 2021
Transactions value $
$607,845
Form type
4
Filing time
02 Sep 2021, 17:00:53 UTC
Previous filing
31 Aug 2021
Next filing
08 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CANO Class A Common Stock Purchase $69.9K +5.83K +0.39% $11.99* 1.52M 31 Aug 2021 Direct F1
transaction CANO Class A Common Stock Purchase $30K +2.5K +3.84% $11.99* 67.6K 31 Aug 2021 See footnote F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CANO Warrants to purchase Class A Common Stock Purchase $356K +94.3K +32.84% $3.77* 381K 31 Aug 2021 Class A Common Stock 94.3K $11.50 Direct F2
transaction CANO Warrants to purchase Class A Common Stock Purchase $152K +40.4K +615.39% $3.77* 47K 31 Aug 2021 Class A Common Stock 40.4K $11.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.96 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $3.62 to $3.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(2) to this Form 4.
F3 These shares are held indirectly by the reporting person through the Marlow B. Hernandez 2020 Family Trust.